| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.23 | 7e-06 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.21 | 8e-06 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.18 | 4e-05 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.12 | 9e-05 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.001 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |